Avantor (AVTR) Stock Price, News & Analysis

$24.28
-0.51 (-2.06%)
(As of 05/13/2024 ET)
Today's Range
$24.25
$24.83
50-Day Range
$23.94
$26.07
52-Week Range
$16.63
$26.16
Volume
5.72 million shs
Average Volume
5.70 million shs
Market Capitalization
$16.49 billion
P/E Ratio
62.26
Dividend Yield
N/A
Price Target
$26.71

Avantor MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
10.0% Upside
$26.71 Price Target
Short Interest
Healthy
3.68% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.27
Upright™ Environmental Score
News Sentiment
1.58mentions of Avantor in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$151,911 Sold Last Quarter
Proj. Earnings Growth
22.77%
From $1.01 to $1.24 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.63 out of 5 stars

Medical Sector

80th out of 925 stocks

Analytical Instruments Industry

5th out of 28 stocks

AVTR stock logo

About Avantor Stock (NYSE:AVTR)

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

AVTR Stock Price History

AVTR Stock News Headlines

Beyond The Numbers: 10 Analysts Discuss Avantor Stock
Avantor Inc. (AVTR) Q1 2024 Earnings Call Transcript
Avantor, Inc Q1 Profit Decreases, but beats estimates
Avantor® Reports First Quarter 2024 Results
Avantor Q1 2024 Earnings Preview
Bank of America Securities Keeps Their Buy Rating on Avantor (AVTR)
RBC Capital Keeps Their Buy Rating on Avantor (AVTR)
9 Analysts Assess Avantor: What You Need To Know
AVTR Mar 2024 27.500 put
AVTR Mar 2024 26.000 call
See More Headlines
Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/26/2024
Today
5/13/2024
Next Earnings (Estimated)
7/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Fax
N/A
Employees
14,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$26.71
High Stock Price Target
$30.00
Low Stock Price Target
$22.00
Potential Upside/Downside
+8.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
16 Analysts

Profitability

Net Income
$321.10 million
Pretax Margin
4.88%

Debt

Sales & Book Value

Annual Sales
$6.97 billion
Cash Flow
$1.67 per share
Book Value
$7.77 per share

Miscellaneous

Free Float
670,436,000
Market Cap
$16.79 billion
Optionable
Optionable
Beta
1.36
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

AVTR Stock Analysis - Frequently Asked Questions

Should I buy or sell Avantor stock right now?

16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last year. There are currently 4 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AVTR shares.
View AVTR analyst ratings
or view top-rated stocks.

What is Avantor's stock price target for 2024?

16 brokerages have issued twelve-month price targets for Avantor's stock. Their AVTR share price targets range from $22.00 to $30.00. On average, they predict the company's share price to reach $26.71 in the next year. This suggests a possible upside of 10.0% from the stock's current price.
View analysts price targets for AVTR
or view top-rated stocks among Wall Street analysts.

How have AVTR shares performed in 2024?

Avantor's stock was trading at $22.83 at the start of the year. Since then, AVTR stock has increased by 6.4% and is now trading at $24.29.
View the best growth stocks for 2024 here
.

Are investors shorting Avantor?

Avantor saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 27,600,000 shares, a drop of 5.8% from the March 31st total of 29,290,000 shares. Based on an average trading volume of 5,380,000 shares, the days-to-cover ratio is presently 5.1 days.
View Avantor's Short Interest
.

When is Avantor's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, July 26th 2024.
View our AVTR earnings forecast
.

How were Avantor's earnings last quarter?

Avantor, Inc. (NYSE:AVTR) released its quarterly earnings results on Friday, April, 26th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.20 by $0.02. The firm had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.68 billion. Avantor had a net margin of 3.79% and a trailing twelve-month return on equity of 13.01%. Avantor's quarterly revenue was down 5.6% compared to the same quarter last year. During the same period last year, the business posted $0.29 earnings per share.

What guidance has Avantor issued on next quarter's earnings?

Avantor updated its FY 2024 earnings guidance on Wednesday, February, 14th. The company provided EPS guidance of 0.960-1.040 for the period, compared to the consensus estimate of 1.060. The company issued revenue guidance of -.

What other stocks do shareholders of Avantor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Johnson & Johnson (JNJ), NVIDIA (NVDA), Procter & Gamble (PG), RTX (RTX), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Pfizer (PFE) and QUALCOMM (QCOM).

When did Avantor IPO?

Avantor (AVTR) raised $3 billion in an initial public offering on Friday, May 17th 2019. The company issued 154,000,000 shares at $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies served as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Who are Avantor's major shareholders?

Avantor's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.49%), Artemis Investment Management LLP (1.34%), Robeco Schweiz AG (0.84%), Westfield Capital Management Co. LP (0.77%), CCLA Investment Management (0.69%) and TD Asset Management Inc (0.46%). Insiders that own company stock include Christophe Couturier, David D Petratis, Devashish Ohri, Frederic Vanderhaegen, Gerard Brophy, James Bramwell, Jo Natauri, Justin Miller, Michael Stubblefield, Rajiv Gupta, Steven W Eck and Thomas A Szlosek.
View institutional ownership trends
.

How do I buy shares of Avantor?

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:AVTR) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners